Linzi Thomas

412 total citations
11 papers, 198 citations indexed

About

Linzi Thomas is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Linzi Thomas has authored 11 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Linzi Thomas's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Melanoma and MAPK Pathways (3 papers). Linzi Thomas is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Melanoma and MAPK Pathways (3 papers). Linzi Thomas collaborates with scholars based in United Kingdom, Italy and Germany. Linzi Thomas's co-authors include J N Baxter, J. Cronin, Gareth Jenkins, Chris Tselepis, Paul Griffiths, James Manson, Hayley Hutchings, John G Williams, Alan Watkins and Philip J. Atherton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The American Journal of Gastroenterology.

In The Last Decade

Linzi Thomas

11 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linzi Thomas United Kingdom	7	78	49	47	38	33	11	198
Peter YF. Zeng Canada	9	59 0.8×	41 0.8×	101 2.1×	16 0.4×	28 0.8×	28	238
Yun‐Ru Liu Taiwan	11	67 0.9×	37 0.8×	167 3.6×	17 0.4×	52 1.6×	23	305
Job J.W.W. Martens Netherlands	2	99 1.3×	75 1.5×	62 1.3×	14 0.4×	9 0.3×	2	311
Łukasz Durko Poland	7	123 1.6×	70 1.4×	61 1.3×	30 0.8×	22 0.7×	17	225
Minhua Hu China	9	49 0.6×	20 0.4×	150 3.2×	20 0.5×	21 0.6×	28	282
Xianyuan Wang China	9	41 0.5×	18 0.4×	39 0.8×	10 0.3×	15 0.5×	20	190
Federica Rubbino Italy	8	80 1.0×	36 0.7×	96 2.0×	27 0.7×	20 0.6×	10	229
Rebecca Roberts New Zealand	5	32 0.4×	63 1.3×	58 1.2×	151 4.0×	7 0.2×	7	313
S. R. Hamilton United States	8	70 0.9×	94 1.9×	73 1.6×	49 1.3×	44 1.3×	16	285
Kiyoto Mori Japan	8	22 0.3×	63 1.3×	65 1.4×	164 4.3×	23 0.7×	12	314

Countries citing papers authored by Linzi Thomas

Since Specialization

Citations

This map shows the geographic impact of Linzi Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linzi Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linzi Thomas more than expected).

Fields of papers citing papers by Linzi Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linzi Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linzi Thomas. The network helps show where Linzi Thomas may publish in the future.

Co-authorship network of co-authors of Linzi Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Linzi Thomas. A scholar is included among the top collaborators of Linzi Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linzi Thomas. Linzi Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

McArthur, Grant A., James Larkin, Brigitte Dréno, et al.. (2015). 25LBA Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) + vemurafenib (VEM) in the phase 3 coBRIM study. European Journal of Cancer. 51. S722–S723. 7 indexed citations

Larkin, James, Jean‐Jacques Grob, C. Lance Cowey, et al.. (2015). Efficacy and Safety in Key Patient Subgroups of Nivolumab (Nivo) Alone Or Combined with Ipilimumab (Ipi) Versus Ipi Alone in Treatment-Naive Patients with Advanced Melanoma. 2 indexed citations

Larkin, James, Vanna Chiarion‐Sileni, R. Gonzalez, et al.. (2015). 3303 Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patients with advanced melanoma (MEL) (CheckMate 067). European Journal of Cancer. 51. S664–S665. 27 indexed citations

Seagrove, Anne C, M Fasihul Alam, Laith Alrubaiy, et al.. (2014). Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT). BMJ Open. 4(4). e005091–e005091. 45 indexed citations

Thomas, Linzi, et al.. (2014). Medical management of Crohn's disease and ulcerative colitis. Surgery (Oxford). 32(8). 418–420. 2 indexed citations

Cronin, J., et al.. (2011). What's Hot in the Red Journal This Month. The American Journal of Gastroenterology. 106(1). 1–3. 1 indexed citations

Wolchok, J. D., Linzi Thomas, Igor Bondarenko, et al.. (2011). Phase III randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma.. Journal of Clinical Oncology. 29(15_suppl). LBA5–LBA5. 17 indexed citations

Cronin, J., Chris Tselepis, Paul Griffiths, et al.. (2010). Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in High-Grade Dysplasia and Adenocarcinoma of the Esophagus and May Represent a Biomarker of Histological Progression in Barrett's Esophagus (BE). The American Journal of Gastroenterology. 106(1). 46–56. 59 indexed citations

Hutchings, Hayley, K. Wareham, J N Baxter, et al.. (2010). A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. SHILAP Revista de lepidopterología. 2011. 1–8. 27 indexed citations

10.

Grob, Jean‐Jacques, Omid Hamid, Jedd D. Wolchok, et al.. (2009). 9312 Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs). European Journal of Cancer Supplements. 7(2). 580–580. 7 indexed citations

11.

Coombes, R. Charles, et al.. (1986). A double blind randomised clinical trial of adjuvant aminoglutethimide versus placebo given to post menopausal patients with histologically confirmed stage II breast cancer.. PubMed. 7 Suppl. S37–40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact